Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
CNASHighly Regulated (List I)TranslatedBECLATE - NASAL
50µG/BOUFFEE/Nasal Aerosol/BECLOMETASONE
ManufacturerVerified lab
CIPLA
Public retail price
N/ADZD
Reference price (TR): 415.20 DZD
Identification
- Active ingredient (INN)
- BECLOMETASONE
- Internal code
- 20 A 072
- Country of Origin
- India
- Pharmaceutical form
- Nasal Aerosol
- Prescription List
- Highly Regulated (List I)
- Packaging
- flacon./120doses
Clinical View
CNAS Highly Regulated (List I)
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
It is used as a long-term preventive treatment for reed cramping for asthma patients.
- chronic obstructive pulmonary disease treatment.
- gastrointestinal tract treatment.
Associated Conditions
The patient may have convulsions with whistles after inhalation of medication.
- medication may discourage adrenaline.
- the use of long-term medication may weaken the immune system and increase the risk of secondary infections.
- medication must be used with caution with eye disease such as blue or black.
- medicine must be used with caution for heart disease, diabetes, digestive tract disease, liver function impairment, muscular osteoporosis, osteoporosis, and kidney function impairment, seizures and thyroid disease.
Mechanism of Action
He belongs to the working-processed steroids group: anti-inflammation reduces the incidence of acute asthma but does not treat the seizure after it has occurred.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions.
Write your question here, Sina is preparing the answer for you.